TurtleTree Labs, a biotech startup based in San Francisco and Singapore that produces milk using cell-based technology, has raised a $6.2M Pre-Series A funding round from new and existing global investors including UAE-based KBW Ventures. Other investors included Green Monday Ventures, Eat Beyond Global, and Verso Capital.
The company also announced that HRH Prince Khaled bin Alwaleed bin Talal Al Saud, a prominent global investor in the alternative protein sector through KBW Ventures, will join TurtleTree Labs as an Advisor. KBW Ventures first invested in TurtleTree Labs Seed round in June of this year.
In his role as Advisor, Prince Khaled will shape new market growth plans, lend his expertise in the alternative protein and food tech spheres, and liaise closely with the founding team on other areas of the business.
TurtleTree Labs will use the funds to accelerate research and production of functional, bioactive proteins and complex sugars found in human milk. These high-value components have potential benefits in gut and brain health, which can be applied to both infant and senior nutrition.
Discover more than 350 UAE-based Technology startups on MAGNiTT
Fengru Lin, CEO of TurtleTree Labs commented, "TurtleTree Labs' groundbreaking technology, which allowed our company to win The Liveability Challenge and Entrepreneurship World Cup, has certainly attracted interest from a global and diverse panel of investors and customers."
Ana Maria Torres, Director for the Entrepreneurship World Cup added, "TurtleTree Labs represents the spirit and impact of the Entrepreneurship World Cup where they emerged from a pool of 175,000 registrants from 200 countries. This investment and the continued support it will receive from a global network of ecosystem leaders provides them with an opportunity to scale in a rapidly-changing industry while addressing an extensive global need."
Are you a startup looking for investment? Apply for funding to 100+ investors now